1.
Kazuya Sakai, Tatsuhiko Someya, Kaori Harada, Hideo Yagi, Taei Matsui, Masanori Matsumoto. Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab. haematol [Internet]. 2019Dec.19 [cited 2024Feb.29];105(11):2631-8. Available from: https://haematologica.org/article/view/9575